Dechert

Comment: A recommended firm in Frankfurt, which continues to expand into the biotech and life science sector, as its work for Selvita in setting up Nodthera Ltd, an Edinburgh-based biotech company, shows. Its respected investment fund practice gained equity partner Dr. Joachim Kayser from PwC Legal, who has expertise in alternative investments. Tax partner Klaus Hahne from Allen & Overy has also joined the team. This replaces the expertise lost when Dr. Martin Haisch left for Noerr. With his specialties in tax advice to credit institutions and financial service providers, Hahne covers the areas that were lost when Haisch left.
Strengths: Transaction advice in the pharma/healthcare sector, ?investment funds.
Recommended: Sven Schulte-Hillen, Dr. Rüdiger Herrmann (both corporate), Achim Pütz (investment funds).
Practice: Banking and finance (esp. investment funds, regulatory, capital markets), cross border advice on ?M&A and corporate finance transactions and restructuring; antitrust. (5 equity partners, 4 salary partners, 9 associates)
Clients: ?? German Real Estate Funds on private placement of a second share; Luxcara on structuring of Renewable Energy Funds; Luxembourg Investment Solutions on setting up an alternative investment platform for institutional investors; 4SC on license and development partnership with Guangzhou LingSheng Pharma Tech; Selvita S.A. on setting up Nodthera Ltd.
  • Teilen